drug
as of 2026-07-01Cross-sectional assessment
at a glance
OTHER
Pre-approval / investigational in the US
Developed by Central South University
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
OTHER
Indications
Trials
2
KOLs & investigators
1
Renrong Wu, M.D., Ph.D.KOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
indication
indication
indication
KOL
Renrong Wu, M.D., Ph.D.
personKOL score 5